期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Detection of chemicals in water using a three-dimensional graphene porous structure as liquid-vapor separation filter
1
作者 Taekyung Lim jaejun lee +1 位作者 Jonghun lee Sanghyun Ju 《Nano Research》 SCIE EI CAS CSCD 2017年第3期971-979,共9页
In this study, we report the utilization of a three-dimensional (3D) porous graphene structure as liquid-vapor separation filter, which allows the passage of chemical vapors while blocking liquid chemicals and water... In this study, we report the utilization of a three-dimensional (3D) porous graphene structure as liquid-vapor separation filter, which allows the passage of chemical vapors while blocking liquid chemicals and water. The blockage of liquid chemicals and water from semiconducting sensing regions is required to avoid abnormal transistor characteristics. In order to impart omniphobic characteristics, a (heptadecafluoro-1,1,2,2-tetrahydrodecyl)trichlorosilane (HDF-S) self-assembled monolayer was coated on the surface of the 3D porous graphene structure. The concentration of chemical agents in water could be consistently detected by observing the shift in the threshold voltage in the oxide nanowire transistor covered by the HDF-S self-assembled 3D graphene structure. The proposed monitoring method is expected to offer means for application in different environments by providing a stable sensing performance. 展开更多
关键词 chemical detection graphene structure nanowire transistor self-assembled monolayer omniphobicity
原文传递
Heterogenous responses to nivolumab in a single metastatic nodule in hepatocellular carcinoma: role of salvage surgery
2
作者 Hyun Yang Pil Soo Sung +4 位作者 jaejun lee Seung Kew Yoon Eun Sun Jung Cheon-Soo Park Si Hyun Bae 《Hepatobiliary Surgery and Nutrition》 SCIE 2019年第5期569-571,共3页
A recent report demonstrated immune heterogeneityof hepatocellular carcinoma(HCC)(1).The objectiveresponse rates of sorafenib-treated global and Asian patientsby nivolumab,the monoclonal antibody to programmedcell dea... A recent report demonstrated immune heterogeneityof hepatocellular carcinoma(HCC)(1).The objectiveresponse rates of sorafenib-treated global and Asian patientsby nivolumab,the monoclonal antibody to programmedcell death protein-1,were only 14%and 15%,respectively(2,3). 展开更多
关键词 HEPATOCELLULAR nivolumab SURGERY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部